A Double-blinded Evaluation of Safety and Efficacy of Hylaform and Hylaform Plus Compared to Zyplast.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00288470|
Recruitment Status : Completed
First Posted : February 8, 2006
Last Update Posted : March 18, 2015
|Condition or disease||Intervention/treatment||Phase|
|Facial Wrinkles||Device: Hylaform, Hylaform Plus (hylan B gel)||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Study Start Date :||June 2002|
|Study Completion Date :||August 2003|
- Non-inferiority as compared to standard of care as assigned by blinded reviewer.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00288470
|Study Director:||Medical Monitor||Genzyme, a Sanofi Company|